Clinical Trials for Myelodysplastic Syndromes

201011766

Tissue Acquisition for Analysis of Genetic Progression Factors in Hematologic Diseases Phase N/A Principal Investigator Westervelt, Peter Disease Site Hodgkin Lymphoma; Leukemia, other; Lymphoid Leukemia; Multiple Myeloma; Myeloid and Monocytic Leukemia; Non-Hodgkin Lymphoma; Other Hematopoietic

201905082

A Phase Ib Study of AZD6738 for Patients with Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia Progressing on Front-Line Therapy Phase I (Cancer Control) Principal Investigator Jacoby, Meagan Disease Site Myeloid and Monocytic Leukemia; Other Hematopoietic…

201906041

A Phase 1b Study of SEL120 in Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Phase I Principal Investigator Abboud, Camille Disease Site Myeloid and Monocytic Leukemia; Other Hematopoietic Learn more about this study…

201911201

Identification of AML/MDS drug sensitization by in vivo chemotherapy administration Phase N/A Principal Investigator Jacoby, Meagan Disease Site Myeloid and Monocytic Leukemia; Other Hematopoietic Learn more about this study at: clinicaltrials.gov

202007148

ENHANCE: A Randomized, Double-blind, Multicenter Study Comparing Magrolimab in Combination with Azacitidine versus Azacitidine Plus Placebo in Treatment-naïve Patients with Higher Risk Myelodysplastic Syndrome Phase III (Cancer Control) Principal Investigator Abboud, Camille Disease Site Other…

202011122

A Phase 2 Trial Evaluating the Efficacy of Flotetuzumab for Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Following Allogeneic Hematopoietic Cell Transplantation (allo-HCT) Phase II Principal Investigator Christopher, Matthew Disease Site Myeloid and…

202103204

A Phase 1, Open-Label, Dose-Finding Study of CC-91633 (BMS-986397) in Subjects with Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes Phase I Principal Investigator Uy, Geoffrey Disease Site Acute Myeloid…

202105123

A Prospective Study of Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

202111071

A Phase I/II, Dose-Escalation study of MGTA-117 in patients with Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB) Phase I/II (Cancer Control) Principal Investigator Westervelt, Peter Disease Site Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome…